The small molecule drug CBL0137 increases the level of DNA damage and the efficacy of radiotherapy for glioblastoma von Tallman, Miranda M., Zalenski, Abigail A., Deighen, Amanda M., Schrock, Morgan S., Mortach, Sherry, Grubb, Treg M., Kastury, Preetham S., Huntoon, Kristin, Summers, Matthew K., Venere, Monica

Volltext

RDNA-03. TARGETING THE EPIGENETIC REMODELING FACTOR FACT TO RADIOSENSITIZE GLIOBLASTOMA CANCER STEM CELLS von Huntoon, Kristin, Deighen, Amanda, Venere, Monica

Volltext

STEM-12. THE SMALL MOLECULE DRUG CBL0137 INCREASES THE LEVEL OF DNA DAMAGE AND THE EFFICACY OF RADIOTHERAPY FOR GLIOBLASTOMA von Tallman, Miranda, Zalenski, Abby, Deighen, Amanda, Grubb, Treg, Schrock, Morgan, Mortach, Sherry, Kastury, Preetham, Huntoon, Kristin, Summers, Matthew, Venere, Monica

Volltext

STEM-04. MECHANISM OF DYSREGULATION AND EFFICACY OF PHARMACOLOGICALLY TARGETING THE APC/C IN GLIOBLASTOMA von De, Kuntal, Deighen, Amanda, Grubb, Treg, Summers, Matthew, Venere, Monica

Volltext

STEM-20. RADIO-SENSITIZING GLIOBLASTOMA CANCER STEM CELLS BY INHIBITION OF FACT von Montgomery, Miranda, Zalenski, Abigail, Deighen, Amanda, Mortach, Sherry, Grubb, Treg, Venere, Monica

Volltext

STEM-26. SMALL MOLECULE DRUG CBL0137 INHIBITS THE FACT COMPLEX AND SENSITIZES GLIOBLASTOMA CANCER STEM CELLS TO RADIOTHERAPY von Tallman, Miranda, Zalenski, Abigail, Deighen, Amanda, Schrock, Morgan, Mortach, Sherry, Grubb, Treg, Kastury, Preetham, Huntoon, Kristin, Summers, Matthew, Venere, Monica

Volltext